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A B S T R A C T
Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome included among idiopathic generalized
epilepsies (IGE) and syndromes with age-related onset. Recently, it has been shown that a few patients
with BMEI later had other epilepsy types mainly IGE but never childhood absence epilepsy (CAE).
We report a patient who at 11 months of age showed isolated myoclonic jerks occurring several times
a day. The ictal video-EEG and polygraphic recording revealed generalized discharge of spike-wave (SW)
lasting 1–2 s associated with isolated bilateral synchronous jerk involving mainly the upper limbs
controlled by valproic acid (VPA).
At 6 years and 8 months the child developed a new electroclinical feature recognized as CAE. The ictal
EEG disclosed a burst of rhythmic 3 Hz generalized SW.
Our case is the ﬁrst patient with BMEI reported in the literature who later developed a CAE.
This ﬁnding suggests a common neurobiological and genetic link between different age-related
epileptic phenotypes.
 2011 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome
ﬁrst described by Dravet and Bureau1 with about 160 patients
reported in other studies on this subject.2–4 BMEI was included
among idiopathic generalized epilepsies and syndromes with age-
related onset in ILAE Classiﬁcation .5 BMEI is characterized by brief,
generalized myoclonic seizures occurring, without other seizure
types except rare simple febrile seizures (FS), within 3 years of age
in developmentally normal children. However, some cases have a
later onset up to 4 years 8 months. The ictal electroencephalogram
(EEG) shows a generalized discharge of polyspikes, polyspike-
waves, or spike-waves (SW). The interictal EEG is usually normal.
Seizures are easily controlled by valproic acid (VPA) and disappear
during childhood. Typically BMEI has good prognosis, however
recent studies reported a less favourable cognitive outcome in a
few cases.2,4,6,7 Long-term follow-up studies reported that a few
children with BMEI after a seizure-free time interval developed
other epileptic phenotypes, mainly IGE, such as rare generalized
tonic–clonic seizures (GTCS), or juvenile myoclonic epilepsy
(JME).2,4,8* Corresponding author. Tel.: +39 091 6555400; fax: +39 091 6555027.
E-mail address: manganos@katamail.com (S. Mangano).
1059-1311/$ – see front matter  2011 Published by Elsevier Ltd on behalf of British 
doi:10.1016/j.seizure.2011.06.008We report a female child with BMEI which occurred at age 11
months, followed by childhood absence epilepsy (CAE) at 6 years
and 8 months old. To the best of our knowledge this occurrence has
never been previously described.
2. Case report
The proband, a female child, was the ﬁrst daughter born to
healthy unrelated parents. Her family history was unremarkable
with regard to neurological and psychiatric diseases except for FS
of the sister and a maternal uncle. She was born at term following
an uneventful pregnancy with a birth weight of 3300 kg. The
postnatal course was uneventful until 11 months of age when she
showed isolated myoclonic jerks involving mainly her arms and
head, occurring several times a day which were misdiagnosed for
ﬁve months. At 12 months she was able to walk with support, and
at 17 months without support. She spoke her ﬁrst word at 14
months, and at 30 months she produced two word-phrases. At age
of 16 months she was referred to our Child Neuropsychiatric
Department at the University of Palermo because the frequency of
myoclonic jerks had increased to 20–30/die.
On admission the ictal video-EEG and polygraphic recording
revealed generalized discharge of SW lasting 1–2 s associated with
an isolated bilateral synchronous jerk involving mainly the upperEpilepsy Association.
Fig. 1. Brief bilateral synchronous jerk related to generalized discharge of spike and
wave complex.
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showed age appropriate background activity.
The results of blood and urine examination were within normal
range.
On neurological examination, cranial nerves were unaffected,
muscle tone and deep tendon reﬂexes were normal. In addition,
the patient did not show speciﬁc minor facial or other physical
anomalies.
Thus clinical and laboratory data led to BMEI diagnosis which
required VPA treatment at the dose of 30 mg/kg/die. The VPA
(109 g/ml) induced a seizure control within 11 days, but
generalized spike-wave discharges, unrelated to clinical seizures,
were still detected on EEG recordings during drowsiness at 5 years
and 8 months of age. This ﬁnding suggested a long lasting
antiepileptic treatment.
The psychomotor development, assessed using the Bayley
Scales of Infant Development [BSID-II; Bayley14], showed that the
Mental Developmental Index and Psychomotor Developmental
Index were 76, both performances were classiﬁed as mildly
delayed.
At two years old she experienced a febrile seizure despite AED
treatment.
At 4 years of age a battery of standardized cognitive and
neuropsychological tests was carried out to evaluate: intellectual
functioning [Wechsler Preschool and Primary Scale of Intelligence,WPPSI; Wechsler; Orsini and Picone15], language expressive and
receptive abilities including word and sentence comprehension,
sentence repetition, naming, morphological and phonological
accuracy, sentence structure [Language Evaluation Test, TVL,
Cianchetti and Sannio Fancello12], and visuospatial integration
ability [Visual Motor Integration test, VMI, Beery and Buktenica13].
The WPPSI showed a full scale IQ of 75, Verbal IQ = 80 and
Performance IQ = 74. Comparison of patient scores to published
norms on tests of language evaluation showed that the perfor-
mances on sentence repetition, naming, morpho and phonological
accuracy, and sentence structure subtests were within 5%ile (lower
average range). The performances on word and sentence compre-
hension subtests were poor being below 5%ile.
Visualmotor integration ability was in the below average range
(VMI = 84).
A new intellectual assessment at 5 years and 9 months of age
showed a full scale IQ-WPPSI of 71 with a slight difference between
verbal IQ (77) and performance IQ (69).
At the same session, a neuropsychological examination
assessed: language (verbal ﬂuency, naming, syntactic comprehen-
sion), verbal short term memory (digit span), verbal episodic
memory (immediate and delayed word list recall, word pair
learning), visual–spatial short term memory (Corsi Test), selective
attention (attentional matrices) [Developmental Neuropsycholog-
ical Battery, BVN 5-11, Bisiacchi17, and visual spatial integration
ability VMI, Rey ﬁgure B copy16].
The comparison of patient scores to published norms on tests of
the neuropsychological battery showed an even overall proﬁle in
the lower average range. Only visual motor integration abilities
were very poor (standard score 60).
In addition, the patient showed oppositional behaviour and
ﬁdgeting.
At 6 years and 8 months old the child had a new seizure type
characterized by motor arrest, eye staring, abrupt and severe
impairment of consciousness lasting a few seconds at frequency of
10–15 daily. The ictal EEG disclosed a burst of rhythmic 3 Hz
generalized SW lasting 10–12 s (Fig. 2) and the interictal EEG
during wakefulness and during sleep showed age appropriate
background activity. Because the clinical and EEG ﬁndings
suggested childhood absence epilepsy and the plasma level of
VPA was 47 g/ml, at a lower level of the normal range, the dose of
VPA was increased but it was ineffective in seizure control. Thus,
ESM was started in add-on at the dose of 10 mg/kg/die and the
child became seizure free.
In order to exclude associated cerebral lesions or genetic
disorders in our patient we carried out a magnetic resonance
imaging (MRI) study and genetic investigations.
Brain MRI at 8 years of age did not show characteristic
abnormalities. Cytogenetic analysis revealed 46 XX karyotype and
the array-CGH analysis did not detect genomic rearrangements.
3. Discussion
The electroclinical feature, the clinical course, the personal and
family history of febrile seizure, the lack of chromosome
rearrangements and of abnormalities on brain MRI of our patient
lead us to a diagnosis of BMEI.2
Indeed, some long-term follow-up studies have shown that
seizure control was achieved in all cases, usually after a short time
from treatment onset, and VPA in monotherapy was effective in
more than 80% of patients with BMEI.2,4,7,8 Conversely, generalized
or focal SW discharges persisted during sleep for several years after
seizure control and antiepileptic treatment was long-lasting in
many cases.2,4,8
Furthermore, the cognitive and neuropsychological ﬁndings of
our patient show an overall proﬁle in the lower average range
Fig. 2. Burst of rhythmic 3 Hz generalized spike and wave complexes during absence seizure.
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from very mild to severe level, were described in 15% of patients
with BMEI in some studies previously published.2–4,6,8 It is likely
that longitudinal, wider, and formal neuropsychological assess-
ments of all patients could detect more disabilities than those
reported. The relation between cognitive outcome and the earlier
seizure onset and/or the delay in the start of the treatment is not
fully clear, so other unknown factors might play a role in the
cognitive outcome of patients with BMEI.2,6–8
In addition, recent long-term follow-up studies are providing
valuable information on seizure and EEG outcomes in this rare
syndrome.
In a recent review, Dravet and Bureau2 evaluated the follow-up
of 79 cases (63 lasting 5 years) with BMEI reported in the
literature.
They found that generalized myoclonic seizures disappeared in
all these cases and most patients were seizure-free within one
year.
Among these patients however, 13 developed other seizure
types, later in life. Rare GTCS were reported in 11/13 patients,
whereas the remaining two patients, described by Prats-Vin˜as
et al.,9 manifested absences. One patient had a ‘‘petit mal status’’ at
10 years old, after the drug withdrawal and a free interval, the
other patient had ‘‘brief absences with marked eyelid myoclonia
controlled by ESM’’ at 11 years old. This data suggests that both
patients might have been affected by juvenile absence epilepsy
(JAE), but essential clinical information such as EEG ﬁndings were
missing.Another longitudinal study,8 mean period of 8 years 9 months,
including 22 patients, reported that 4 patients developed
occasional isolated convulsive seizures that were induced by IPS
or TV screens in 3 and unprovoked in one.
Furthermore, a long-term follow-up of 34 new patients with
BMEI4 reported 9 patients developing seizures after the
disappearance of the initial myoclonic seizures. Among them
5 patients showed FS, one had a GTCS after VPA discontinuation,
2 patients developed JME at the ages of 9 and 12 years,
respectively. In another patient, cryptogenic partial epilepsy
developed 12 months after a ﬁrst generalized seizure at 6 years
old.
The later development of CAE detected in our patient provides
additional data on the outcome of BMEI. Since both BMEI and CAE
belong to idiopathic generalized epilepsy, the occurrence of these
phenotypes in our patient likely reﬂects the dynamic age-
dependent expression of a common genetic factor rather than a
casual association.8
The age-dependent transition from an epileptic phenotype to
another is being increasingly recognized in different early-onset
idiopathic epilepsies such as idiopathic occipital lobe epilepsy10
and benign familial neonatal infantile seizures11 and likely
involves pathogenetic mechanisms superimposed on physiological
processes regulating normal brain development.
Our study indicates the need to further investigate the
relationship between the two syndromes and to elucidate the
pathogenetic mechanisms of the evolution of BMEI to CAE as well
as any common neurobiological and genetic substrate.
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